1 |
HU F, WANG M, ZHU D, et al. CHINET efforts to control antimicrobial resistance in China[J]. Journal of global antimicrobial resistance, 2020, 21: 76-77.
|
2 |
CHEN S, FENG W, CHEN J, et al. Spread of carbapenemase-producing enterobacteria in a Southwest hospital in China[J]. Annals of clinical microbiology and antimicrobials, 2014, 13(1): 42.
|
3 |
KUMARASAMY K K, TOLEMAN M A, WALSH T R, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: A molecular, biological, and epidemiological study[J]. The lancet infectious diseases, 2010, 10(9): 597-602.
|
4 |
PATEL G, HUPRIKAR S, FACTOR S H, et al. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies[J]. Infection control and hospital epidemiology, 2008, 29(12): 1099-1106.
|
5 |
SCHWABER M J, KLARFELD-LIDJI S, NAVON-VENEZIA S, et al. Predictors of carbapenem-resistant klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality[J]. Antimicrobial agents and chemotherapy, 2008, 52(3): 1028-1033.
|
6 |
ÇÖLKESEN F, TARAKÇı A, EROĞLU E, et al. Carbapenem-resistant klebsiella pneumoniae infection and its risk factors in older adult patients[J]. Clinical interventions in aging, 2023, 18: 1037-1045.
|
7 |
BORER A, SAIDEL-ODES L, RIESENBERG K, et al. Attributable mortality rate for carbapenem-resistant klebsiella pneumoniae bacteremia[J]. Infection control and hospital epidemiology, 2009, 30(10): 972-976.
|
8 |
SUAY-GARCÍA B, PÉREZ-GRACIA M T. Present and future of carbapenem-resistant enterobacteriaceae (CRE) infections[J]. Antibiotics, 2019, 8(3): 122.
|
9 |
STEWARDSON A J, MARIMUTHU K, SENGUPTA S, et al. Effect of carbapenem resistance on outcomes of bloodstream infection caused by enterobacteriaceae in low-income and middle-income countries (PANORAMA): A multinational prospective cohort study[J]. The lancet infectious diseases, 2019, 19(6): 601-610.
|
10 |
TACCONELLI E, CARRARA E, SAVOLDI A, et al. Discovery, research, and development of new antibiotics: The WHO priority list of antibiotic-resistant bacteria and tuberculosis[J]. The lancet infectious disease, 2018, 18(3): 318-327.
|
11 |
全国细菌耐药监测网. 全国细菌耐药监测网2014—2019年耐碳青霉烯类肺炎克雷伯菌流行病学变迁[J]. 中国感染控制杂志, 2021, 20(2): 175-179.
|
12 |
KALLEN A, GUH A. United states centers for disease control and prevention issue updated guidance for tackling carbapenem-resistant enterobacteriaceae[J]. Euro surveillance: Bulletin européen sur les maladies transmissibles, 2012, 17(26): 20207.
|
13 |
CHEN Y, CHEN Y, LIU P, et al. Risk factors and mortality for elderly patients with bloodstream infection of carbapenem resistance Klebsiella pneumoniae: A 10-year longitudinal study[J]. BMC geriatrics, 2022, 22(1): 573.
|
14 |
LOGAN L K. Carbapenem-resistant enterobacteriaceae: An emerging problem in Children[J]. Clinical infectious diseases, 2012, 55(6): 852-859.
|
15 |
TIAN L, TAN R, CHEN Y, et al. Epidemiology of klebsiella pneumoniae bloodstream infections in a teaching hospital: Factors related to the carbapenem resistance and patient mortality[J]. Antimicrobial resistance and infection control, 2016, 5: 48.
|
16 |
JIAO Y, QIN Y, LIU J, et al. Risk factors for carbapenem-resistant klebsiella pneumoniae infection/colonization and predictors of mortality: A retrospective study[J]. Pathogens and global health, 2015, 109(2): 68-74.
|
17 |
闫力煜,黎毅敏.重症监护病房中耐碳青霉烯类肠杆菌科细菌感染相关危险因素的研究[J]. 中国现代医学杂志, 2022, 32(7): 89-94.
|
18 |
康霞, 黄文治, 卫丽, 等. 急诊重症监护室多重耐药菌主动筛查的流行病学研究[J]. 华西医学, 2021, 36(3): 328-333.
|
19 |
BARBER K E, WAGNER J L, LARRY R C, et al. Frequency of and risk factors for carbapenem-resistant enterobacteriaceae[J]. Journal of medical microbiology, 2021, 70(2): 001286.
|
20 |
TORRES-GONZALEZ P, CERVERA-HERNANDEZ M E, NIEMBRO-ORTEGA M D, et al. Factors associated to prevalence and incidence of Carbapenem-resistant enterobacteriaceae fecal carriage: A cohort study in a Mexican tertiary care hospital[J]. PloS one, 2015, 10(10): e0139883.
|
21 |
QIN X, WU S, HAO M, et al. The Colonization of carbapenem-resistant klebsiella pneumoniae: Epidemiology, resistance mechanisms, and risk factors in patients admitted to intensive care units in China[J]. The journal of infectious diseases, 2020, 221(Supplement_2): S206-S214.
|
22 |
MCCONVILLE T H, SULLIVAN S B, GOMEZ-SIMMONDS A, et al. Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study[J]. PloS one, 2017, 12(10): e0186195.
|
23 |
夏粉芳, 郑春梅, 姜丹, 等. 神经外科重症监护室耐碳青霉烯类肠杆菌科细菌主动筛查结果[J]. 中华医院感染学杂志, 2021, 31(22): 3427-3431.
|
24 |
陈美恋, 王守军, 匡季秋, 等. 重症监护病区CRE主动筛查及其效果评价[J]. 中华医院感染学杂志, 2017, 27(18): 4123-4126.
|
25 |
WANG Q, WANG X, WANG J, et al. Phenotypic and genotypic characterization of carbapenem-resistant enterobacteriaceae: Data from a longitudinal large-scale CRE study in China (2012—2016)[J]. Clinical infectious diseases: An official publication of the infectious diseases society of america, 2018, 67(suppl_2): S196-S205.
|
26 |
WANG Y, WANG J, WANG R, et al. Resistance to ceftazidime–avibactam and underlying mechanisms[J]. Journal of global antimicrobial resistance, 2020, 22: 18-27.
|
27 |
KIDDEE A, ASSAWATHEPTAWEE K, NA-UDOM A, et al. Risk factors for gastrointestinal colonization and acquisition of carbapenem-resistant gram-negative bacteria among patients in intensive care units in Thailand[J]. Antimicrobial agents and chemotherapy, 2018, 62(8): e00341-18.
|
28 |
ZHENG B, DAI Y, LIU Y, et al. Molecular epidemiology and risk factors of carbapenem-resistant klebsiella pneumoniae infections in eastern China[J]. Frontiers in microbiology, 2017, 8: 1061.
|
29 |
Li Y, Xia X, Li X, et al. Correlation between the use of antibiotics and development of a resistant bacterial infection in patients in the ICU[J]. Bioscience trends, 2018, 12(5): 517-519.
|
30 |
杜洁.对神经内科监护室重症患者耐碳青霉烯类肠杆菌科细菌(CRE)筛查的相关研究[D]. 荆州:长江大学, 2021.
|
31 |
HUANG X L, WU S H, SHI P F, et al. Active screening of intestinal carbapenem-resistant Enterobacteriaceae in high-risk patients admitted to the hematology wards and its effect evaluation[J]. Chinese journal of hematology, 2020, 41(11): 932-936.
|